EMFAT
IRWD icon

Emerald Mutual Fund Advisers Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-197,396
Closed -$813K – 225
2024
Q3 		$813K Sell
197,396
-446,757
-69% -$2.4M 0.04% 147
2024
Q2 		$4.2M Hold
644,153
– – 0.22% 107
2024
Q1 		$5.61M Buy
+644,153
New +$7.82M 0.29% 103

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's IRWD Position: Q4 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 197,396 shares — an estimated $813K sold.

Emerald Mutual Fund Advisers Trust first reported a position in IRWD in Q1 2024 and held it in 3 quarters. The position peaked at $5.61M in Q1 2024. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 197,396 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $813K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Ironwood Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Ironwood Pharmaceuticals position peaked at $5.61M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2024, filed 14 Feb 2025.